A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT04767529 · COMPLETED
Trial details
- NCT number
- NCT04767529
- Sponsor
- Akero Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-16
- Primary completion
- 2024-05-02
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.